Isolagen Inc. Completes Registered Direct Offering of Common Stock

Friday, August 24, 2007 General News J E 4
EXTON, Pa., Aug. 23 Isolagen(TM), Inc.(Amex: ILE) today announced that it completed its previously announcedregistered direct offering of approximately 6.76 million shares of commonstock at a price of $2.04 per share to institutional investors for grossproceeds of approximately $13.8 million. The shares were offered under aneffective shelf registration statement previously filed with the Securitiesand Exchange Commission.

This press release shall not constitute an offer to sell or thesolicitation of an offer to buy these securities, nor shall there be any saleof these securities in any state or jurisdiction in which such offer,solicitation or sale would be unlawful prior to registration or qualificationunder the securities laws of any such state or jurisdiction.

About Isolagen, Inc.

Isolagen(TM), Inc. (Amex: ILE) is an aesthetic and therapeutic companycommitted to developing and commercializing scientific advances and innovativetechnologies. The company's technology platform includes the IsolagenProcess(TM), a cell processing system for skin and tissue rejuvenation whichis currently in clinical development for a broad range of aesthetic andtherapeutic applications including wrinkles, acne scars, burns and periodontaldisease. Isolagen also commercializes a scientifically-advanced line ofskincare systems through its majority-owned subsidiary, Agera(R) Laboratories,Inc. For additional information, please visit

SOURCE Isolagen(TM), Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
RTX Healthcare Receives FDA 510k Market Clearance ...
AspenBio Pharma Shares to Trade on the NASDAQ Capi...